Dossier
Connexus
Coverage of Connexus in the Nexus archive.
- Neuralink competitor Paradromics just implanted its first brain-chip device. The next step is restoring speech.
Paradromics, a brain-computer interface startup and Neuralink competitor, implanted its first human brain-chip device in a patient with motor neuron disease at the University of Michigan in early June. The Connexus device aims to restore speech by translating neural activity into text or synthesized speech through software, with testing expected to begin soon.